Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.36 is in line with its 5-year average of 4.48, near the low end of its 5-year range (1.79–18.08).
As of the fiscal period ended Tuesday, June 30, 2026. 9.02% above its 12-month average of 4.00.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.36.
CURRENT RATIO
4.36
CURRENT RATIO AVG TTM
4.00
CURRENT RATIO AVG 3Y
3.01
CURRENT RATIO AVG 5Y
4.48
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.02%
CURRENT VS 3Y AVG
+44.78%
CURRENT VS 5Y AVG
-2.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+15.94%
vs the sector median at left
Market Cap
$70.63M
Current Ratio
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
Market Cap
$72.32M
Current Ratio
1.45
TTM Avg
2.17
3Y Avg
5.05
5Y Avg
3.92
Market Cap
$69.61M
Current Ratio
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$68.90M
Current Ratio
6.12
TTM Avg
4.89
3Y Avg
4.59
5Y Avg
6.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $71.23M | 4.36 | 4.00 | 3.01 | 4.48 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $70.63M | 0.76 | 0.89 | 1.63 | 3.63 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | 1.45 | 2.17 | 5.05 | 3.92 |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | 1.84 | 2.44 | 2.28 | 3.54 |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | 1.03 | 0.95 | 0.86 | 0.95 |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | 6.15 | 5.25 | 8.81 | 10.73 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 6.12 | 4.89 | 4.59 | 6.09 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 3.96 | 1.88 | 1.73 | 2.58 |
| iBio, Inc. (IBIO)vs › | $67.52M | 7.85 | 4.72 | 3.68 | 5.33 |
| Pulmonx Corporation (LUNG)vs › | $75.18M | 4.32 | 5.33 | 6.57 | 9.68 |
Current Ratio
4.36
Quick Ratio
4.36
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.36 |
| 2026-03-31 | 4.69 |
| 2025-12-31 | 6.63 |
| 2025-09-30 | 2.52 |
| 2025-06-30 | 1.79 |
| 2025-03-31 | 2.22 |
| 2024-12-31 | 2.97 |
| 2024-09-30 | 2.99 |
| 2024-06-30 | 2.84 |
| 2024-03-31 | 2.77 |
| 2023-12-31 | 3.59 |
| 2023-09-30 | 2.30 |
| 2023-06-30 | 3.10 |
| 2023-03-31 | 3.75 |
| 2022-12-31 | 5.11 |
| 2022-09-30 | 5.62 |
| 2022-06-30 | 7.58 |
| 2022-03-31 | 8.63 |
| 2021-12-31 | 14.78 |
| 2021-09-30 | 11.62 |
| 2021-06-30 | 18.08 |
| 2021-03-31 | 20.37 |
| 2020-12-31 | 4.25 |
| 2020-09-30 | 10.82 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.45 |
| 2019-09-30 | 0.49 |
| 2019-06-30 | 0.49 |
| 2019-03-31 | 0.49 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
